MRD: an important topic in myeloma therapy
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
Biomarkers of cardiotoxicity in multiple myeloma
ASH 2015 highlights in multiple myeloma by Prof. Ola Landgren
How can standard risk multiple myeloma (MM) patients be cured?